LIMITATIONS: True incidence of CPAEs can not be inferred from FAERS. Using #CIBMTR registry data (Thanks @mpasca!), we extrapolate an incidence of at least 13.7% (in line with previous reports) 9/x https://t.co/lkwyflyWkQ
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T). https://t.co/KeNxLaV1n2
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T). #lymphoma #lymsm https://t.co/hJTfzz8OAe
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) https://t.co/t8ycW87M1j #clinicalresearch #clinicaltrials #endpointadjudication #electronichealthrecords #clinicalstudies #digitalsignatures #patientengagement #phar
RT @MariaSolAndres1: Last week I got a call from the @royalmarsdenNHS to review a patient with #CRS and fast AF... I had to google what CRS…
RT @raza_alvi786: Very excited and thankful for being selected for the American College of Cardiology’s William W. Parmley Young Author Ach…
RT @raza_alvi786: Very excited and thankful for being selected for the American College of Cardiology’s William W. Parmley Young Author Ach…
RT @raza_alvi786: Very excited and thankful for being selected for the American College of Cardiology’s William W. Parmley Young Author Ach…
Very excited and thankful for being selected for the American College of Cardiology’s William W. Parmley Young Author Achievement Award for our paper. #JACC #CART #ACC20 #Cardioonc https://t.co/xfgH0U5nig
RT @Borjaibanez1: @BolanosNat @TheEBMT_CTIWP @EHA_Hematology @knowyournodes Agree!! Multidisciplinary cardio-oncology units critical to mon…
@BolanosNat @TheEBMT_CTIWP @EHA_Hematology @knowyournodes Agree!! Multidisciplinary cardio-oncology units critical to monitor toxicities. Recommend this paper in @JACCJournals to learn about CAR-T associated cardiotoxicity. https://t.co/Ha0i0k5VBx https://
RT @CampbellMDPhD: CAR-T & CV events: - "a graded relationship among cytokine release syndrome (CRS), elevated troponin, and CV events"…
RT @CampbellMDPhD: CAR-T & CV events: - "a graded relationship among cytokine release syndrome (CRS), elevated troponin, and CV events"…
RT @CampbellMDPhD: CAR-T & CV events: - "a graded relationship among cytokine release syndrome (CRS), elevated troponin, and CV events"…
RT @CampbellMDPhD: CAR-T & CV events: - "a graded relationship among cytokine release syndrome (CRS), elevated troponin, and CV events"…
RT @CampbellMDPhD: CAR-T & CV events: - "a graded relationship among cytokine release syndrome (CRS), elevated troponin, and CV events"…
CAR-T & CV events: - "a graded relationship among cytokine release syndrome (CRS), elevated troponin, and CV events" - "a shorter time from CRS onset to tocilizumab was associated with a lower rate of CV events." @JACCJournals https://t.co/QFi5O9Nl0
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) https://t.co/bD8LwT0Z3o via @nuzzel
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MDonatoBMT: 12% CV events, all in pts w >= grade 2 CRS, median time 👉🏻21 days 😳😬 @ASTCT #bmtsm #cart @ACCinTouch https://t.co/u29GlNbMne
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
Cardiovascular events under CAR T cells : more with cytokine release strom and better with earlier tocilizumab https://t.co/uSvWeTJlAP
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
RT @MJFzeta: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American Coll…
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American College of Cardiology https://t.co/3QQYmLzwnU
CV Events Among Adults Treated With CAR T-Cell Therapy. Original Article (https://t.co/U59pCcGc55), Editorial Comment (https://t.co/A5yjlItt6s)and JACC Council Perspectives (https://t.co/STdv5r5uIu) #cardiotwitter #Oncology https://t.co/bXMDNLOBTA
RT @raza_alvi786: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) | JACC: Journal of the American…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @DrRaulCordoba: #OncoAlert Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells #CARTcell #ImmunoOnc #Cardi…
RT @DrRaulCordoba: #OncoAlert Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells #CARTcell #ImmunoOnc #Cardi…
RT @DrRaulCordoba: #OncoAlert Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells #CARTcell #ImmunoOnc #Cardi…
RT @DrRaulCordoba: #OncoAlert Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells #CARTcell #ImmunoOnc #Cardi…
Cardiovascular Events Among Adults Treated With #CART https://t.co/bW8tumSXiU
RT @DrRaulCordoba: #OncoAlert Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells #CARTcell #ImmunoOnc #Cardi…
RT @DrRaulCordoba: #OncoAlert Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells #CARTcell #ImmunoOnc #Cardi…
RT @DrRaulCordoba: #OncoAlert Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells #CARTcell #ImmunoOnc #Cardi…
RT @DrRaulCordoba: #OncoAlert Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells #CARTcell #ImmunoOnc #Cardi…
#OncoAlert Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells #CARTcell #ImmunoOnc #CardioOnc https://t.co/4IanRc0mb1
RT @CARTTherapy: Cardiovascular Events Among Adults Treated With Chimeric Antigen Recep... https://t.co/qxvBCZDNKb
RT @CARTTherapy: Cardiovascular Events Among Adults Treated With Chimeric Antigen Recep... https://t.co/qxvBCZDNKb
RT @vrichard_rouen: Adverse cardiac effects of CAR-T cells - not so surprising #CardioOncology https://t.co/3gWV4qeFDK
RT @vrichard_rouen: Adverse cardiac effects of CAR-T cells - not so surprising #CardioOncology https://t.co/3gWV4qeFDK
RT @vrichard_rouen: Adverse cardiac effects of CAR-T cells - not so surprising #CardioOncology https://t.co/3gWV4qeFDK
Adverse cardiac effects of CAR-T cells - not so surprising #CardioOncology https://t.co/3gWV4qeFDK
Cardiovascular Events Among Adults Treated With Chimeric Antigen Recep... https://t.co/qxvBCZDNKb
RT @Transplant_Doc: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) #cartcell #immunotherapy #bmt…
RT @Transplant_Doc: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) #cartcell #immunotherapy #bmt…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @Transplant_Doc: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) #cartcell #immunotherapy #bmt…
RT @Transplant_Doc: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) #cartcell #immunotherapy #bmt…
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) #cartcell #immunotherapy #bmtsm #cardiooncology https://t.co/tHCeqtGK6w
New research examines how common CV events/injury are in cancer patients treated with Chimeric antigen receptor T-cells (CAR-T). How will these findings impact the future of cardio-oncology care?@JACCJournals https://t.co/iwmxOChHBK
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @Lymphoma_Papers: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T). #lymphoma #lymsm https://t.…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
RT @JACCJournals: How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's…
How common are CV events/injury in #cancer patients treated with Chimeric antigen receptor T-cells (CAR-T)? This week's #JACC reports on the possible cardiac toxicities that can originate from CAR-T. https://t.co/94mD6e86DJ #CardioOnc @MGHHeartHealth http
RT @Lymphoma_Papers: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T). #lymphoma #lymsm https://t.…
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T). #lymphoma #lymsm https://t.co/C4BYOE20vm
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T). https://t.co/KeNxLaV1n2
New article: Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T). https://t.co/JaKtnmw6VY #MMSM #MultipleMyeloma #hematology
RT @MariaSolAndres1: Last week I got a call from the @royalmarsdenNHS to review a patient with #CRS and fast AF... I had to google what CRS…
'Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)' via @JACCJournals #immunotherapy #genetherapy https://t.co/6RHvpppWNi
RT @MariaSolAndres1: Last week I got a call from the @royalmarsdenNHS to review a patient with #CRS and fast AF... I had to google what CRS…
RT @MariaSolAndres1: Last week I got a call from the @royalmarsdenNHS to review a patient with #CRS and fast AF... I had to google what CRS…
RT @MariaSolAndres1: Last week I got a call from the @royalmarsdenNHS to review a patient with #CRS and fast AF... I had to google what CRS…
RT @MariaSolAndres1: Last week I got a call from the @royalmarsdenNHS to review a patient with #CRS and fast AF... I had to google what CRS…